| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
53,173 |
46,615 |
$4.00M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
39,911 |
35,018 |
$3.46M |
| G0378 |
Hospital observation service, per hour |
13,381 |
7,550 |
$2.16M |
| 41899 |
Unlisted procedure, dentoalveolar structures |
1,471 |
1,324 |
$1.10M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
6,938 |
6,470 |
$842K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
9,818 |
8,538 |
$831K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
24,341 |
21,188 |
$656K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
9,151 |
8,684 |
$631K |
| 93975 |
|
3,415 |
3,004 |
$503K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
14,548 |
11,515 |
$461K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
5,099 |
4,898 |
$414K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
12,228 |
10,083 |
$341K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
2,160 |
2,020 |
$286K |
| 70450 |
Computed tomography, head or brain; without contrast material |
5,275 |
4,870 |
$198K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
519 |
448 |
$196K |
| 80053 |
Comprehensive metabolic panel |
31,251 |
24,642 |
$159K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
6,111 |
5,232 |
$154K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,093 |
1,956 |
$146K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
3,260 |
3,045 |
$136K |
| 71045 |
Radiologic examination, chest; single view |
19,139 |
16,926 |
$116K |
| 85027 |
|
56,097 |
42,189 |
$115K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
4,248 |
3,991 |
$103K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,739 |
3,393 |
$100K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
20,682 |
17,238 |
$98K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
14,815 |
11,588 |
$98K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
28,148 |
24,104 |
$97K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,056 |
2,787 |
$95K |
| 76830 |
Ultrasound, transvaginal |
1,776 |
1,614 |
$92K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,371 |
1,291 |
$89K |
| 71046 |
Radiologic examination, chest; 2 views |
6,157 |
5,781 |
$73K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
1,336 |
1,252 |
$72K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
87 |
84 |
$72K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
18,395 |
8,805 |
$71K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,935 |
1,777 |
$70K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
1,498 |
1,235 |
$60K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
26,910 |
22,005 |
$59K |
| 93971 |
|
1,464 |
1,324 |
$55K |
| 83880 |
|
4,349 |
3,915 |
$51K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,371 |
1,160 |
$49K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,895 |
2,743 |
$44K |
| 80076 |
|
12,108 |
10,457 |
$42K |
| 84484 |
|
10,115 |
8,081 |
$42K |
| 84703 |
|
15,718 |
14,022 |
$42K |
| 83690 |
|
17,243 |
15,144 |
$41K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,900 |
2,747 |
$41K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,367 |
1,297 |
$40K |
| 73564 |
|
1,810 |
1,604 |
$37K |
| 81001 |
|
20,752 |
18,728 |
$37K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
575 |
520 |
$36K |
| 87070 |
|
3,328 |
3,147 |
$35K |
| 96376 |
|
5,367 |
3,291 |
$31K |
| 87430 |
|
4,975 |
4,746 |
$31K |
| 84702 |
|
4,382 |
3,625 |
$30K |
| 73130 |
|
1,542 |
1,417 |
$28K |
| 73610 |
|
1,490 |
1,376 |
$28K |
| 73630 |
|
1,710 |
1,595 |
$28K |
| 90715 |
|
1,252 |
1,199 |
$26K |
| 87040 |
|
4,689 |
3,597 |
$26K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
634 |
610 |
$25K |
| 81025 |
|
10,031 |
9,228 |
$24K |
| 0450 |
Emergency room services |
449 |
416 |
$24K |
| 10060 |
|
187 |
175 |
$21K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,117 |
2,966 |
$21K |
| 74018 |
|
1,780 |
1,655 |
$21K |
| 80047 |
|
4,105 |
3,534 |
$20K |
| 76801 |
|
649 |
573 |
$20K |
| 83605 |
|
3,299 |
2,751 |
$19K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,634 |
1,403 |
$18K |
| 73030 |
|
1,289 |
1,168 |
$18K |
| 12001 |
|
270 |
256 |
$18K |
| 73110 |
|
829 |
775 |
$17K |
| G0330 |
Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room |
473 |
461 |
$16K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
2,005 |
1,886 |
$16K |
| 72100 |
|
1,204 |
1,110 |
$16K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
87 |
72 |
$16K |
| 82550 |
|
6,164 |
5,212 |
$16K |
| 59025 |
Fetal non-stress test |
147 |
132 |
$15K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,451 |
980 |
$15K |
| 97163 |
|
818 |
655 |
$15K |
| 82077 |
|
3,512 |
3,073 |
$14K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
9,167 |
6,743 |
$14K |
| G0383 |
Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
429 |
311 |
$13K |
| 85610 |
|
10,917 |
9,081 |
$13K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,416 |
2,172 |
$13K |
| 93970 |
|
247 |
227 |
$13K |
| 85730 |
|
8,057 |
6,898 |
$13K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
18,812 |
11,478 |
$13K |
| 93976 |
|
179 |
160 |
$12K |
| 83735 |
|
7,598 |
4,934 |
$12K |
| J7050 |
Infusion, normal saline solution, 250 cc |
9,709 |
8,745 |
$12K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,459 |
2,186 |
$11K |
| 87088 |
|
3,701 |
3,423 |
$11K |
| 87420 |
|
1,104 |
1,058 |
$11K |
| 97161 |
|
332 |
309 |
$10K |
| J3490 |
Unclassified drugs |
3,160 |
2,738 |
$9K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,193 |
2,512 |
$9K |
| 85379 |
|
2,359 |
2,191 |
$9K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
5,076 |
3,407 |
$8K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
446 |
325 |
$7K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
5,440 |
4,794 |
$7K |
| 70496 |
|
61 |
52 |
$7K |
| 87077 |
|
1,687 |
1,589 |
$7K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
1,407 |
1,231 |
$7K |
| 87210 |
|
1,679 |
1,574 |
$7K |
| 70486 |
|
90 |
86 |
$6K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
87 |
72 |
$6K |
| 12011 |
|
84 |
81 |
$6K |
| 81003 |
|
5,434 |
4,995 |
$5K |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
53 |
48 |
$5K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
16,206 |
13,004 |
$5K |
| 73502 |
|
285 |
264 |
$5K |
| 86901 |
|
5,226 |
4,357 |
$4K |
| 86900 |
|
5,227 |
4,357 |
$4K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,149 |
1,565 |
$4K |
| 97165 |
|
187 |
166 |
$4K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
6,189 |
5,239 |
$4K |
| C1776 |
Joint device (implantable) |
53 |
38 |
$4K |
| 84100 |
|
4,480 |
2,477 |
$4K |
| 86920 |
|
346 |
265 |
$4K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,905 |
1,662 |
$4K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
1,188 |
825 |
$4K |
| 97162 |
|
219 |
189 |
$3K |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
165 |
152 |
$3K |
| 73080 |
|
201 |
186 |
$3K |
| 86850 |
|
2,981 |
2,421 |
$3K |
| 87186 |
|
816 |
772 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,194 |
1,059 |
$3K |
| 80061 |
Lipid panel |
813 |
726 |
$3K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,004 |
585 |
$3K |
| 72050 |
|
128 |
126 |
$3K |
| 76857 |
|
107 |
98 |
$3K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
3,857 |
3,348 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
651 |
563 |
$2K |
| 72131 |
|
39 |
37 |
$2K |
| S0028 |
Injection, famotidine, 20 mg |
2,172 |
1,973 |
$2K |
| 97166 |
|
89 |
78 |
$2K |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
728 |
500 |
$2K |
| 85007 |
|
1,547 |
1,327 |
$2K |
| 70491 |
|
25 |
25 |
$2K |
| 95816 |
|
14 |
12 |
$2K |
| 97116 |
|
175 |
103 |
$2K |
| J1815 |
Injection, insulin, per 5 units |
1,808 |
867 |
$2K |
| J1630 |
Injection, haloperidol, up to 5 mg |
1,436 |
1,198 |
$2K |
| 73590 |
|
120 |
108 |
$2K |
| 76770 |
|
26 |
25 |
$2K |
| 97535 |
Self-care/home management training, each 15 minutes |
212 |
162 |
$1K |
| 76942 |
|
159 |
143 |
$1K |
| 84439 |
|
432 |
379 |
$1K |
| 93017 |
|
87 |
72 |
$1K |
| 73140 |
|
45 |
44 |
$1K |
| 93356 |
|
285 |
269 |
$1K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,142 |
952 |
$1K |
| 29125 |
|
13 |
13 |
$899.30 |
| 73090 |
|
41 |
38 |
$804.50 |
| 70498 |
|
16 |
12 |
$714.45 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
86 |
51 |
$706.17 |
| 86140 |
|
487 |
453 |
$670.24 |
| 86592 |
|
109 |
103 |
$664.71 |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,317 |
652 |
$630.61 |
| J2060 |
Injection, lorazepam, 2 mg |
1,434 |
1,205 |
$621.74 |
| 96368 |
|
92 |
88 |
$536.94 |
| C9113 |
Injection, pantoprazole sodium, per vial |
484 |
324 |
$532.70 |
| 71101 |
|
28 |
27 |
$517.32 |
| 99152 |
|
193 |
161 |
$507.11 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
725 |
420 |
$475.31 |
| 82553 |
|
176 |
134 |
$448.64 |
| J0456 |
Injection, azithromycin, 500 mg |
174 |
162 |
$421.73 |
| 82248 |
|
962 |
786 |
$417.55 |
| 80069 |
|
410 |
266 |
$413.69 |
| 84112 |
|
13 |
12 |
$401.75 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,007 |
2,310 |
$366.27 |
| 96367 |
|
27 |
24 |
$355.77 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
1,297 |
1,153 |
$353.90 |
| 73560 |
|
29 |
26 |
$322.98 |
| J1790 |
Injection, droperidol, up to 5 mg |
149 |
134 |
$308.80 |
| 15853 |
|
14 |
13 |
$275.00 |
| 0250 |
|
45 |
27 |
$230.51 |
| 72072 |
|
12 |
12 |
$229.92 |
| 85651 |
|
268 |
252 |
$221.16 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
139 |
83 |
$170.51 |
| 36430 |
|
33 |
25 |
$161.65 |
| 82607 |
|
64 |
62 |
$149.77 |
| J2704 |
Injection, propofol, 10 mg |
1,703 |
1,310 |
$144.84 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
487 |
441 |
$124.78 |
| M0239 |
Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring |
16 |
14 |
$116.10 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
139 |
127 |
$115.49 |
| J7999 |
Compounded drug, not otherwise classified |
62 |
56 |
$96.92 |
| 76870 |
|
12 |
12 |
$89.22 |
| J2800 |
Injection, methocarbamol, up to 10 ml |
39 |
27 |
$81.60 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,740 |
1,259 |
$80.74 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
179 |
157 |
$78.77 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
63 |
44 |
$64.24 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
16 |
13 |
$59.04 |
| 82140 |
|
19 |
15 |
$49.70 |
| 88304 |
|
98 |
83 |
$45.34 |
| 82746 |
|
13 |
13 |
$40.12 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
150 |
107 |
$39.78 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
59 |
53 |
$38.33 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
12 |
12 |
$32.86 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
20 |
17 |
$32.04 |
| 84132 |
|
259 |
178 |
$25.12 |
| 85018 |
|
39 |
24 |
$22.68 |
| J7510 |
Prednisolone oral, per 5 mg |
16 |
16 |
$21.22 |
| 83550 |
|
13 |
12 |
$9.56 |
| 85049 |
|
26 |
24 |
$9.49 |
| J1940 |
Injection, furosemide, up to 20 mg |
19 |
14 |
$7.80 |
| 83540 |
|
13 |
12 |
$7.78 |
| J3480 |
Injection, potassium chloride, per 2 meq |
14 |
13 |
$2.38 |
| A9270 |
Non-covered item or service |
15,300 |
3,671 |
$0.00 |
| C1769 |
Guide wire |
441 |
377 |
$0.00 |
| 99153 |
Mod sedat endo service >5yrs |
13 |
12 |
$0.00 |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
14 |
12 |
$0.00 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
670 |
533 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
13 |
12 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
184 |
148 |
$0.00 |